Data / Form D filings / Beacon Biosignals, Inc.
Beacon Biosignals, Inc.: Form D filings
Beacon Biosignals, Inc., a technology company in Boston, MA, filed 3 Form D notices with the SEC between 2019 and 2026. The latest, on April 15, 2026, reports $103.3 million sold of a $103.3 million offering to 43 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22 Boston Wharf Road Floor 7, Boston, MA, 02210
- Phone
- (401) 225-5782
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1765647
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | New notice | $103,280,711 | $103,280,711 | 43 | Oct 7, 2025 | sec.gov | |
| Oct 4, 2021 | New notice | $29,850,019 | $29,850,019 | 42 | Sep 17, 2021 | sec.gov | |
| Feb 7, 2019 | New notice | $1,600,000 | $50,000 | $1,550,000 | 1 | Jan 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacob A. Donoghue, M.D., Ph.D. | Executive Officer, Director | |
| Jarrett Revels | Executive Officer | |
| Caitlin Donovan | Director | |
| Pavel Raifeld | Director | |
| Naveen Rao | Director |
Other technology companies in Massachusetts that filed recently
- Betvisors, Inc. $150,000 · Oct 30, 2026
- RESOLV TECHNOLOGY, INC. $7.2 million · Oct 30, 2026
- Cala Systems, Inc. $2.6 million · Oct 27, 2026
- Boltz, PBC $97.4 million · Oct 22, 2026
- SpartanX Technologies, Inc. $5 million · Oct 22, 2026
- Govably, Inc. $375,000 · Oct 21, 2026
Every Form D from the week of Apr 13, 2026 · All recent filings in Massachusetts · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Beacon Biosignals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.